# Dave Inc.: financial statements, quarterly

DAVE · Nasdaq · CIK 1841408 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dave.md) · [Financials](/companies/dave/financials.md) · [Filings](/companies/dave/filings.md) · [Insiders](/companies/dave/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dave/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [65.8](/filings/0000950170-24-125522.md) | [73.1 d](/filings/0001193125-26-085370.md) | [73.6](/filings/0000950170-25-067073.md) | [80.1](/filings/0000950170-25-103967.md) | [92.5](/filings/0001193125-25-264819.md) | [101 d](/filings/0001193125-26-085370.md) | [108](/filings/0001193125-26-206446.md) | [132](/filings/0001193125-26-335154.md) | [151](/filings/0001193125-25-264819.md) | [164 d](/filings/0001193125-26-085370.md) | [158](/filings/0001193125-26-206446.md) | [171](/filings/0001193125-26-335154.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [3.1](/filings/0000950170-24-125522.md) | [2.8 d](/filings/0001193125-26-085370.md) | [2.2](/filings/0000950170-25-067073.md) | [2.0](/filings/0000950170-25-103967.md) | [2.0](/filings/0001193125-25-264819.md) | [1.8 d](/filings/0001193125-26-085370.md) | [1.8](/filings/0001193125-26-206446.md) | [1.8](/filings/0001193125-26-335154.md) | [1.8](/filings/0001193125-25-264819.md) | [1.7 d](/filings/0001193125-26-085370.md) | [1.7](/filings/0001193125-26-206446.md) | [2.0](/filings/0001193125-26-335154.md) |
| Income tax | $m | [0.0](/filings/0000950170-24-125522.md) | [0.1 d](/filings/0001193125-26-085370.md) | [3.2](/filings/0000950170-25-067073.md) | [(1.8)](/filings/0000950170-25-103967.md) | [0.4](/filings/0001193125-25-264819.md) | [0.7 d](/filings/0001193125-26-085370.md) | [5.1](/filings/0001193125-26-206446.md) | [2.5](/filings/0001193125-26-335154.md) | [(33.6)](/filings/0001193125-25-264819.md) | [(1.7) d](/filings/0001193125-26-085370.md) | [12.2](/filings/0001193125-26-206446.md) | [8.0](/filings/0001193125-26-335154.md) |
| Net income | $m | [(12.1)](/filings/0000950170-24-125522.md) | [0.2 d](/filings/0001193125-26-085370.md) | [34.2](/filings/0000950170-25-067073.md) | [6.4](/filings/0000950170-25-103967.md) | [0.5](/filings/0001193125-25-264819.md) | [16.8 d](/filings/0001193125-26-085370.md) | [28.8](/filings/0001193125-26-206446.md) | [9.0](/filings/0001193125-26-335154.md) | [92.1](/filings/0001193125-25-264819.md) | [65.9 d](/filings/0001193125-26-085370.md) | [57.9](/filings/0001193125-26-206446.md) | [6.7](/filings/0001193125-26-335154.md) |
| Diluted EPS | $ per share | [(1.01)](/filings/0000950170-24-125522.md) | not reported | [2.60](/filings/0000950170-25-067073.md) | [0.47](/filings/0000950170-25-103967.md) | [0.03](/filings/0001193125-25-264819.md) | not reported | [1.97](/filings/0001193125-26-206446.md) | [0.62](/filings/0001193125-26-335154.md) | [6.34](/filings/0001193125-25-264819.md) | not reported | [4.02](/filings/0001193125-26-206446.md) | [0.49](/filings/0001193125-26-335154.md) |
| Basic EPS | $ per share | [(1.01)](/filings/0000950170-24-125522.md) | not reported | [2.80](/filings/0000950170-25-067073.md) | [0.51](/filings/0000950170-25-103967.md) | [0.04](/filings/0001193125-25-264819.md) | not reported | [2.19](/filings/0001193125-26-206446.md) | [0.68](/filings/0001193125-26-335154.md) | [6.84](/filings/0001193125-25-264819.md) | not reported | [4.31](/filings/0001193125-26-206446.md) | [0.53](/filings/0001193125-26-335154.md) |

- Revenue: us-gaap:Revenues
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [43.6](/filings/0000950170-24-125522.md) | [41.8](/filings/0001193125-26-085370.md) | [55.5](/filings/0000950170-25-067073.md) | [48.6](/filings/0000950170-25-103967.md) | [35.1](/filings/0001193125-25-264819.md) | [49.7](/filings/0001193125-26-085370.md) | [47.0](/filings/0001193125-26-206446.md) | [61.7](/filings/0001193125-26-335154.md) | [49.9](/filings/0001193125-25-264819.md) | [80.5](/filings/0001193125-26-335154.md) | [133](/filings/0001193125-26-206446.md) | [210](/filings/0001193125-26-335154.md) |
| Current assets | $m | [278](/filings/0000950170-23-060316.md) | [277](/filings/0000950170-25-032164.md) | [218](/filings/0000950170-24-054605.md) | [230](/filings/0000950170-24-091896.md) | [255](/filings/0000950170-24-125522.md) | [282](/filings/0001193125-26-085370.md) | [299](/filings/0000950170-25-067073.md) | [346](/filings/0000950170-25-103967.md) | [386](/filings/0001193125-25-264819.md) | [437](/filings/0001193125-26-335154.md) | [480](/filings/0001193125-26-206446.md) | [519](/filings/0001193125-26-335154.md) |
| Total assets | $m | [294](/filings/0000950170-23-060316.md) | [294](/filings/0000950170-25-032164.md) | [236](/filings/0000950170-24-054605.md) | [247](/filings/0000950170-24-091896.md) | [272](/filings/0000950170-24-125522.md) | [299](/filings/0001193125-26-085370.md) | [316](/filings/0000950170-25-067073.md) | [364](/filings/0000950170-25-103967.md) | [433](/filings/0001193125-25-264819.md) | [487](/filings/0001193125-26-335154.md) | [531](/filings/0001193125-26-206446.md) | [571](/filings/0001193125-26-335154.md) |
| Current liabilities | $m | [34.9](/filings/0000950170-23-060316.md) | [25.6](/filings/0000950170-25-032164.md) | [29.2](/filings/0000950170-24-054605.md) | [26.5](/filings/0000950170-24-091896.md) | [37.4](/filings/0000950170-24-125522.md) | [35.1](/filings/0001193125-26-085370.md) | [34.8](/filings/0000950170-25-067073.md) | [36.4](/filings/0000950170-25-103967.md) | [44.4](/filings/0001193125-25-264819.md) | [114](/filings/0001193125-26-335154.md) | [124](/filings/0001193125-26-206446.md) | [123](/filings/0001193125-26-335154.md) |
| Total liabilities | $m | [215](/filings/0000950170-23-060316.md) | [207](/filings/0000950170-25-032164.md) | [108](/filings/0000950170-24-054605.md) | [105](/filings/0000950170-24-091896.md) | [116](/filings/0000950170-24-125522.md) | [116](/filings/0001193125-26-085370.md) | [116](/filings/0000950170-25-067073.md) | [146](/filings/0000950170-25-103967.md) | [142](/filings/0001193125-25-264819.md) | [135](/filings/0001193125-26-335154.md) | [327](/filings/0001193125-26-206446.md) | [363](/filings/0001193125-26-335154.md) |
| Long-term debt | $m | [75.0](/filings/0000950170-23-060316.md) | [75.0](/filings/0000950170-25-032164.md) | [75.0](/filings/0000950170-24-054605.md) | [75.0](/filings/0000950170-24-091896.md) | [75.0](/filings/0000950170-24-125522.md) | [75.0](/filings/0001193125-26-085370.md) | [75.0](/filings/0000950170-25-067073.md) | [75.0](/filings/0000950170-25-103967.md) | [75.0](/filings/0001193125-25-264819.md) | [0.0](/filings/0001193125-26-085370.md) | not reported | not reported |
| Shareholders' equity | $m | [79.2](/filings/0000950170-24-125522.md) | [87.1](/filings/0001193125-26-085370.md) | [127](/filings/0000950170-25-103967.md) | [142](/filings/0001193125-25-264819.md) | [156](/filings/0001193125-25-264819.md) | [183](/filings/0001193125-26-335154.md) | [199](/filings/0001193125-26-335154.md) | [217](/filings/0001193125-26-335154.md) | [291](/filings/0001193125-25-264819.md) | [353](/filings/0001193125-26-335154.md) | [204](/filings/0001193125-26-335154.md) | [208](/filings/0001193125-26-335154.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [15.4 d](/filings/0000950170-24-125522.md) | [15.6 d](/filings/0001193125-26-085370.md) | [18.3](/filings/0000950170-25-067073.md) | [28.0 d](/filings/0000950170-25-103967.md) | [37.0 d](/filings/0001193125-25-264819.md) | [41.7 d](/filings/0001193125-26-085370.md) | [45.2](/filings/0001193125-26-206446.md) | [68.2 d](/filings/0001193125-26-335154.md) | [83.2 d](/filings/0001193125-25-264819.md) | [93.3 d](/filings/0001193125-26-085370.md) | [82.0](/filings/0001193125-26-206446.md) | [68.4 d](/filings/0001193125-26-335154.md) |
| Capital expenditure | $m | [0.1 d](/filings/0000950170-24-125522.md) | [0.0 d](/filings/0001193125-26-085370.md) | [0.0](/filings/0000950170-25-067073.md) | [0.1 d](/filings/0000950170-25-103967.md) | [0.1 d](/filings/0001193125-25-264819.md) | [0.1 d](/filings/0001193125-26-085370.md) | [0.0](/filings/0001193125-26-206446.md) | [0.1 d](/filings/0001193125-26-335154.md) | [0.1 d](/filings/0001193125-25-264819.md) | [0.1 d](/filings/0001193125-26-085370.md) | [0.0](/filings/0001193125-26-206446.md) | [0.2 d](/filings/0001193125-26-335154.md) |
| Share repurchases | $m | [0.0 d](/filings/0000950170-23-060316.md) | [0.0 d](/filings/0001193125-26-085370.md) | [0.0](/filings/0000950170-25-067073.md) | [0.0 d](/filings/0000950170-25-103967.md) | [0.0 d](/filings/0001193125-25-264819.md) | [0.0 d](/filings/0001193125-26-085370.md) | [6.9](/filings/0001193125-26-206446.md) | [0.0 d](/filings/0001193125-26-335154.md) | [25.0 d](/filings/0001193125-25-264819.md) | [11.8 d](/filings/0001193125-26-085370.md) | [187](/filings/0001193125-26-206446.md) | [19.1 d](/filings/0001193125-26-335154.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [11.7](/filings/0000950170-23-060316.md) | [11.8](/filings/0000950170-24-054605.md) | [11.9](/filings/0000950170-24-091896.md) | [12.0](/filings/0000950170-24-125522.md) | [13.2](/filings/0000950170-25-067073.md) | [13.5](/filings/0000950170-25-103967.md) | [13.9](/filings/0001193125-25-264819.md) | [14.6](/filings/0001193125-26-206446.md) | [14.6](/filings/0001193125-26-335154.md) | [14.5](/filings/0001193125-25-264819.md) | [14.4](/filings/0001193125-26-206446.md) | [13.7](/filings/0001193125-26-335154.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.